Brain Atrophy and Cognitive Impairment in Chronic Kidney Disease

被引:23
|
作者
Tsuruya, Kazuhiko [1 ,2 ]
Yoshida, Hisako [2 ,3 ]
机构
[1] Nara Med Univ, Dept Nephrol, 840 Shijocho, Kashihara, Nara 6348521, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka, Fukuoka, Japan
[3] Saga Univ Hosp, Clin Res Ctr, Saga, Japan
关键词
HEMODIALYSIS-PATIENTS; PERITONEAL-DIALYSIS; OXYGEN-METABOLISM; ERYTHROPOIETIN; IMPROVEMENT; RISK;
D O I
10.1159/000485694
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: There is an increasing prevalence of dementia associated with population aging, and anti-dementia measures have now become of increasing importance in Japan. Chronic kidney disease (CKD) is a risk factor for cognitive impairment. Summary: We previously demonstrated that hemodialysis patients have a higher prevalence of brain atrophy, even at younger age, than the general population, and also demonstrated the association between frontal lobe atrophy and frequency of rapid decline in blood pressure during the hemodialysis session. Recently, we demonstrated that decline in gray matter volume in CKD patients on peritoneal dialysis was significantly more rapid compared to non-dialysis-dependent CKD patients, and also showed a close association between gray matter atrophy and executive dysfunction in CKD patients, suggesting the importance of preventing brain atrophy for the prevention of cognitive impairment. Our recent epidemiological study demonstrated that both decreased kidney function and albuminuria were identified as independent risk factors for the development of dementia. In addition, it has been reported that possible contributing factors include anemia, oxidative stress, and the renin-angiotensin system (RAS). Previous reports have demonstrated that CKD patients with severe anemia show cognitive impairment, which was recovered by correction of anemia using erythropoiesis-stimulating agents. Then, we examined the role of oxidative stress and RAS using a mouse model of CKD-associated cognitive impairment, and demonstrated that the RAS inhibitor candesartan, as well as the antioxidant tempol, inhibited the development of cognitive impairment through inhibition of oxidative stress in the hippocampus. Key Messages: In CKD patients, progression of brain atrophy is more rapid and cognitive impairment is more common than in non-CKD subjects. Oxidative stress and RAS in the brain are associated with CKD-associated cognitive impairment. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:27 / 36
页数:10
相关论文
共 50 条
  • [1] Cognitive Impairment and Brain Atrophy in Patients with Chronic Kidney Disease
    Tsuruya, Kazuhiko
    Yoshida, Hisako
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [2] Cognitive impairment and hippocampal atrophy in chronic kidney disease
    Chang, C. -Y.
    Lin, C. -C.
    Tsai, C. -F.
    Yang, W. -C.
    Wang, S. -J.
    Lin, F. -H.
    Fuh, J. -L.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (05): : 477 - 485
  • [3] Chronic Kidney Disease and Cognitive Impairment: The Kidney-Brain Axis
    Xie, Zuoquan
    Tong, Siyu
    Chu, Xingkun
    Feng, Teng
    Geng, Meiyu
    KIDNEY DISEASES, 2022, 8 (04) : 275 - 285
  • [4] Chronic Kidney Disease and Cognitive Impairment
    Murtaza, Asam
    Dasgupta, Indranil
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (09):
  • [5] Chronic kidney disease and cognitive impairment
    Pepin, Marion
    Villain, Cedric
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2020, 18 (04): : 429 - 435
  • [6] Cognitive impairment in chronic kidney disease
    Madan, Pankaj
    Kalra, Om P.
    Agarwal, Sunil
    Tandon, Om P.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (02) : 440 - 444
  • [7] Cognitive impairment in chronic kidney disease
    Kurella, M
    Chertow, GM
    Luan, J
    Yaffe, K
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (11) : 1863 - 1869
  • [8] CHRONIC VALPROATE ENCEPHALOPATHY WITH REVERSIBLE COGNITIVE IMPAIRMENT AND BRAIN ATROPHY
    Caicoya, A. G.
    Yubero, R.
    Jimenez De la Pena, M.
    Gil-Robles, S.
    Arroyo, R.
    EPILEPSIA, 2012, 53 : 186 - 186
  • [9] HOMOCYSTEINE AND COGNITIVE IMPAIRMENT IN CHRONIC KIDNEY DISEASE
    Yeh, Y. -C.
    Kuo, M. -C.
    Hwang, S. -J.
    Hsioa, S. -M.
    Tsai, J. -C.
    Huang, M. -F.
    Chen, C. -S.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [10] Association of brain white matter lesions and atrophy with cognitive function in chronic kidney disease
    Yeh, Yi-Chun
    Kuo, Yu-Ting
    Huang, Mei-Feng
    Hwang, Shang-Jyh
    Tsai, Jer-Chia
    Kuo, Mei-Chuan
    Chen, Cheng-Sheng
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 34 (12) : 1826 - 1832